Agranulocyosis in Beta Thalassemia Major Patients treated with Oral Iron Chelating Agent (Deferiprone)

Wali, Y., Al Shidhani, A., & Daar, S. (2008). Agranulocyosis in Beta Thalassemia Major Patients treated with Oral Iron Chelating Agent (Deferiprone). Oman Medical Journal, 23(4). https://omanscience.com/ar/articles/agranulocyosis-in-beta-thalassemia-major-patients-treated-with-oral-iron-chelating-agent-deferiprone

Wali, Yasser, et al. "Agranulocyosis in Beta Thalassemia Major Patients treated with Oral Iron Chelating Agent (Deferiprone)." Oman Medical Journal, vol. 23, no. 4, 2008. https://omanscience.com/ar/articles/agranulocyosis-in-beta-thalassemia-major-patients-treated-with-oral-iron-chelating-agent-deferiprone.

Wali, Yasser, Azza Al Shidhani, and Shahina Daar. 2008. "Agranulocyosis in Beta Thalassemia Major Patients treated with Oral Iron Chelating Agent (Deferiprone)." Oman Medical Journal 23 (4). https://omanscience.com/ar/articles/agranulocyosis-in-beta-thalassemia-major-patients-treated-with-oral-iron-chelating-agent-deferiprone.

Wali, Y., Al Shidhani, A. and Daar, S. (2008) 'Agranulocyosis in Beta Thalassemia Major Patients treated with Oral Iron Chelating Agent (Deferiprone)', Oman Medical Journal, 23(4). Available at: https://omanscience.com/ar/articles/agranulocyosis-in-beta-thalassemia-major-patients-treated-with-oral-iron-chelating-agent-deferiprone.

Wali Y, Al Shidhani A, Daar S. Agranulocyosis in Beta Thalassemia Major Patients treated with Oral Iron Chelating Agent (Deferiprone). Oman Medical Journal. 2008;23(4). https://omanscience.com/ar/articles/agranulocyosis-in-beta-thalassemia-major-patients-treated-with-oral-iron-chelating-agent-deferiprone

Y. Wali, A. Al Shidhani, and S. Daar, "Agranulocyosis in Beta Thalassemia Major Patients treated with Oral Iron Chelating Agent (Deferiprone)," Oman Medical Journal, vol. 23, no. 4, 2008, https://omanscience.com/ar/articles/agranulocyosis-in-beta-thalassemia-major-patients-treated-with-oral-iron-chelating-agent-deferiprone.